Malformations of cortical development (MCDs) are heterogeneous disorders caused by abnormalities of cell proliferation, apoptosis, cell migration, cortical organization, and axon pathfinding. In severe MCDs, the cerebral cortex can appear completely disorganized, or may be replaced by aberrant laminar patterns, as in B4-layered[ types of lissencephaly and polymicrogyria. Little is known about the abnormal layers in MCDs and whether they bear any relation to normal cortical layers or how MCDs affect specific neuron types. Normally, each layer contains a defined mixture of different types of pyramidal and nonpyramidal neurons. The neuron types are distinguished by molecular expression as well as morphologic, neurochemical, and electrophysiologic criteria. Patterns of layer-specific mRNA and protein expression reflect the segregation of different neuron types into different layers (e.g. corticospinal projection neurons in layer V). Numerous layer-specific markers have been described in rodent cortex, and increasing numbers are being documented in human and monkey cortex. Applied to MCDs, layer-specific markers have the potential to reveal new insights on pathogenesis, treatment possibilities, and genotypeYphenotype correlations. However, much work remains before layer-specific markers become practical tools in diagnostic neuropathology. Additional markers, more extensive documentation of normal expression, and better antibodies compatible with paraffin-embedded tissues will be necessary.
INTRODUCTION
Malformations of cortical development (MCDs) are morphologic disturbances of the cerebral cortex that arise from perturbations of fundamental processes in brain development (1, 2) . The morphologic phenotypes of MCDs are diverse. The principal phenotypes include lissencephaly, polymicrogyria, heterotopia, dysplasia, micrencephaly, and megalencephaly. The severity of the brain defects in MCDs ranges from subtle microdysgenesis (ectopic neurons) to extreme hypoplasia and cortical disorganization (e.g. microlissencephaly). MCDs usually result from genetic mutations that affect cell proliferation, apoptosis, neuron migration, and cortical organization, although nongenetic etiologies (e.g. hypoxiaYischemia and viral infection) can play a role as well. Clinically, MCDs are significant causes of seizures, cerebral palsy, mental retardation, and neuropsychiatric disorders (1Y3).
Current MCD classifications rely on integration of brain morphology and genetic analysis (1, 2) . Morphologic evaluations assign MCDs to descriptive phenotypic categories, whereas genetic studies provide precise molecular diagnoses. This approach is necessary because most MCD phenotypes are not tied to a single gene, chromosomal abnormality, or nongenetic etiology, and different types of mutations in the same gene can cause different phenotypes. Classic (type I) lissencephaly, for example, can be caused by chromosome 17p subtelomeric deletion (Miller-Dieker syndrome) and by at least four different single gene mutations (LIS1, DCX, RELN, and ARX) (4) . Micrencephaly is linked to at least five genetic loci, in addition to several chromosomal syndromes (5) . Likewise, periventricular heterotopia is linked to several single genes and chromosomal abnormalities (6, 7) . Polymicrogyria is even more heterogeneous, with associations to not only genetic mutations (8Y11) but also to fetal hypoxiaYischemia (12Y15) and intrauterine infections (8) . Nevertheless, it seems likely that morphologic evaluation will become increasingly important as additional genes are discovered, additional subtypes of MCDs are distinguished, and genotypeYphenotype correlations are sought. Indeed, phenotypic differences between lissencephaly caused by LIS1 and DCX mutations have already been found. Interestingly, LIS1 lissencephaly affects posterior cortex worse than anterior cortex, whereas DCX lissencephaly shows the reverse gradient (16, 17) . Histologic patterns of cortical lamination also differ between LIS1, DCX, and other forms of lissencephaly (18, 19) .
To some extent, current problems of morphologic diagnosis reflect underlying deficiencies in our knowledge of abnormal cortical histology in MCDs. Descriptive neuropathology has done little to elucidate how histologic phenotypes such as 2-, 3-, and 4-layered lissencephaly (19) and 4-layered and unlayered polymicrogyria (8) , relate to normal 6-layered cortex. In this regard, it is important to remember that layers in normal cortex are not merely patterns of cell distribution, but are specialized compartments containing neurons with unique properties and roles in neural circuitry. For example, neurons that project to the brainstem and spinal cord are located in layer V, whereas corticothalamic neurons are located in layer VI (20) . Abnormal layers in MCDs arise by redistribution of neurons, transforming the normal 6 layers into an abnormal pattern, but the effects on layer-specific neuron types generally cannot be discerned on routine histologic staining. In principle, it should be possible to map the pathways of redistribution and thus link abnormal laminar patterns to their origins from normal cortical layers, using layer-specific molecular markers.
So far, attempts to relate abnormal patterns in MCDs to normal cortical layers have generated reasonable hypotheses but no definitive answers. In polymicrogyria, different explanations for 4-layered and unlayered patterns have been proposed. Caviness and colleagues (12) , using cresyl violet histology, observed continuity of certain layers between normal and 4-layered polymicrogyric cortex and proposed that the 4-layered pattern was produced by laminar destruction of the middle cortical layers. Ferrer and Catalá (13, 14) studied unlayered polymicrogyria, using Golgi impregnations to identify neuronal morphologies characteristic of upper and lower cortical layers. They found that the relative positions of neurons along the radial (deep-superficial) axis were generally preserved, although the apical dendrites of many pyramidal neurons were maloriented. They suggested that the cortical disorganization in unlayered polymicrogyria resulted from irregular scarring due to vascular compromise. Interestingly, the same studies suggested that periventricular heterotopia (present in association with polymicrogyria) contained mainly upper-layer type neurons (14) .
Studies of laminar relations in lissencephaly have reached divergent conclusions. Using routine histologic stains (hematoxylin and eosin, Luxol fast blue, and cresyl violet), Encha-Razavi and colleagues (18) suggested that the cortical layers were overall inverted in LIS1 lissencephaly but were relatively preserved in DCX lissencephaly. Golden and colleagues (19) , relying on neurofilament protein immunohistochemistry in addition to routine stains, reported a Bnear inversion[ of cortical layers in both LIS1 and DCX lissencephaly, although subtle differences between them were also found. In contrast, Sheen et al (21) reached a completely different conclusion. Using layer-specific neuronal markers to study a fetal case of LIS1 lissencephaly in Miller-Dieker syndrome, they found that the positions of cortical layers were relatively preserved and not inverted as suggested by other studies (18, 19) . In particular, neurons immunoreactive for transcription factor FOXP1 were located in deep layers of lissencephalic as well as normal cortex. Additional work will be required to resolve the discrepancies among these studies.
As the recent article by Sheen et al (21) illustrates, layer-specific molecular markers are beginning to be introduced in neuropathologic studies of MCDs, and moreover, this trend is likely to continue. Scores of layer-specific markers have been identified in developing mouse cerebral cortex (20, 22Y33) , and increasing numbers are being documented in monkeys and humans. Layer-specific markers have the potential to enhance both diagnosis and research in developmental neuropathology by revealing how neuronal positions map from layers in normal cortex to abnormal patterns in MCDs. In this article, I review the neurobiology and applications of layer-specific molecular markers, with an emphasis on practical considerations for neuropathologists, including technical aspects, limitations, and caveats. Whereas layer-specific markers are already well-established probes for mouse neurobiology, expanding applications to human neuropathology will require much additional groundwork.
Diversity of Neuron Types and Subtypes Within Cortical Layers
It has been known since the work of Cajal that the cerebral cortex contains 2 main classes of neurons, pyramidal and nonpyramidal neurons, which both encompass multiple distinct types. Pyramidal neurons are the more abundant class, accounting for 75% to 85% of cortical neurons, whereas nonpyramidal neurons account for 15% to 25% (34, 35) . Neurons of the same type frequently occupy the same cortical layer or layers, such as Betz cells (corticospinal neurons) in layer 5 of the motor cortex. In turn, the characteristic anatomical and functional properties of each neuron type depend on its unique molecular expression profile. This fundamental linkage between cortical neuron type, laminar position, and molecular profile is the conceptual foundation for understanding layer-specific gene expression (20) . Thus, layer-specific markers may be understood more accurately as neuron type-specific markers. The principle that layer-specific patterns represent the radial distribution of distinct neuron types is essential for understanding how these patterns arise and for avoiding pitfalls in the interpretation of layer-specific markers.
The diversity of neuron types within layers has been studied most extensively in layer V of rodent cerebral cortex. Layer V contains several distinct types of pyramidal neurons (29, 36, 37) and interneurons (38) (Fig. 1A) . The two main types of pyramidal neurons in layer V are known as tufted (type I) and nontufted (type II), according to the degree of dendrite branching in layer I (37) . Tufted pyramidal neurons make corticobulbar or corticospinal axon projections, contain high levels of neurofilament proteins, and fire bursts of action potentials (29, 37) . In contrast, nontufted pyramidal neurons make corticocortical or corticostriatal axon projections, do not contain neurofilament proteins in the cell body, and fire nonbursting action potentials. Among interneuron types in layer V, the most abundant are large basket cells, although chandelier, Martinotti, bipolar, double bouquet, and bitufted interneurons are also found in layer V (14, 38) . In general, most interneuron types are broadly distributed among layers (38) , although a few types do show laminar specificity, such as calretinin + interneurons in layers II to III (39) .
Neuronal diversity within layers is apparent even in the developing cortex (Fig. 1B) . Indeed, many layer-specific molecular expression patterns and differences between neuron types in the same layer are most prominent during development, when axon pathways, cell positions, and dendritic morphology are being established. Thus, fewer molecular markers show layer-specific patterns in the mature cortex than during development. Neuron type and laminar fate are specified early in development during cortical neurogenesis and subsequently remain set throughout life. The developmental mechanisms that specify neuron type are discussed in greater detail below. 
Layer-Specific Molecular Markers and Neuron Types
Many molecules with layer-specific expression patterns have been identified in mice (20, 22Y33) . Using appropriate panels of markers, it is now possible to map cortical layers and areas with remarkable precision in mice (20, 40Y42) . Eventually, it seems likely that molecular markers will be used to define all cortical neuron types, although that capability is still a distant goal. Many different families of molecules exhibit layer-specific expression patterns, including axon guidance molecules, secreted morphogens, calcium-binding proteins, cytoskeletal proteins, transcription factors, and others. Depending on the type of molecule and its subcellular distribution, layer-specific patterns may be evident from expression of mRNA, protein, or both. Discrepancies between mRNA and protein expression patterns can be seen, for example, with genes in the Eph and ephrin families. These axon guidance molecules show layer-specific mRNA expression, but the proteins are redistributed across layers by axonal transport (43) . In contrast, mRNA and protein laminar patterns are typically identical for molecules with protein localization to the nucleus or perikaryon, such as transcription factors.
Fewer layer-specific markers have been documented in human and monkey than in mouse cerebral cortex, but this is likely to change as additional studies are completed. Not surprisingly, many layer-specific markers in primates belong to the same molecular families as those identified in mice, including Eph and ephrin genes (44), transcription factors (21, 30, 31, 45, 46) , secreted molecules (47Y49), cytoskeletal proteins (50Y54), and calcium-binding proteins (39, 46, 48, 53, 55, 56) . Cytoskeletal proteins and calcium-binding proteins are especially useful for studies of human cortex, because the antigens are relatively resistant to autolysis, formalin fixation, and paraffin embedding and are thus amenable to immunohistochemical analysis using routinely processed brain tissue. For example, cytoskeletal proteins microtubule-associated protein (MAP1B) and neurofilament-H, which label subsets of layer V neurons, are consistently detectable in formalin-fixed, paraffin-embedded autopsy material ( Fig. 2A, B) . Many other antigens are detectable only in cortex that has been specially preserved, for example, by snap freezing. Examples of such antigens include RORA, Ctip2, and TLE4, which exhibit layer-specific expression patterns in frozen sections (Fig. 2C, D) but not in paraffin sections. Finally, probes for mRNA expression could potentially reveal additional layer-specific patterns in humans as in monkeys (30, 31, 44) , but mRNA is usually too degraded for sufficient detection in most human brain specimens.
In humans as in all mammals, Blayer-specific[ markers label a limited set of one or a few cortical neuron types with restricted laminar distribution, not the entire complement of neurons in one layer. Accordingly, many layer-specific markers are actually expressed in multiple layers, and no single marker labels all the neurons in a particular layer. For example, nonphosphorylated neurofilament-H is only expressed in a subset of layer V pyramidal neurons, leaving many layer V pyramidal and nonpyramidal neurons unlabeled (Fig. 2B) . Conversely, nonphosphorylated neurofilament-H is also expressed by some neurons outside layer V, mainly in layers III and VI (51, 53, 54) . Further complications arise from changes in the laminar specificity of markers across cortical areas (30, 31, 40, 42) and developmental stages (22, 26, 33) . Finally, some layer-specific markers can be actively regulated in response to neural activity (51) . All of these factors must be carefully controlled when molecular markers are used as probes for laminar identity.
In human neocortex, layer-specific markers have been used to identify neurons in layer 1 (marginal zone), layers 2 to 3, layer 4, layer 5, layer 6, and the subplate (Fig. 3) . Nevertheless, because of the diversity of neuron types in each layer, the available markers do not cover all neuron types with restricted laminar distribution. For example, no marker specific for layer II/III projection neurons has been documented in human neocortex. Thus, the markers listed in Figure 3 represent a starting point toward the ultimate goal of developing a comprehensive panel of markers to analyze all neuron types and their distribution in the human neocortex. Such a panel would be able to detect abnormalities in the position and number of each neuron type and would be tremendously valuable for evaluating not only malformations of cortical development but also diseases involving selective loss of specific neuron types.
Cortical Neurogenesis, Fate Specification, and Cell Migration
Cortical neurons are produced by neurogenesis in progenitor zones near the lateral ventricles, followed by extensive postmitotic cell migration along radial and nonradial axes (Fig. 4A) . Interestingly, the two main classes of cortical neurons are produced in separate regions of the developing forebrain. Projection neurons are produced in the cortical neuroepithelium (pallium), whereas many or most interneurons are produced in the basal telencephalon (ganglionic eminences) (57Y60). Accordingly, the subsequent migrations of projection neurons and interneurons are also quite different. Projection neurons migrate primarily along the radial axis from progenitor zone to cortical plate, whereas interneurons must migrate both nonradially (to enter cortex from basal forebrain) and radially (to enter the cortical plate). Despite these differences, both classes of neurons demonstrate similar Binside-out[ relations between cell birthday and laminar fate, i.e. early-born neurons FIGURE 3. Layer-specific markers in human neocortex. Expression of each antigen in specific layers of fetal and adult cerebral cortex is indicated by shading. Darker shading indicates stronger expression. The expression of MAP1B, NSE, and FoxP1 in adult cortex has not been reported. This figure is only a rough guide because layer-specific patterns differ among cortical areas and change throughout development. The neuron class and type, optimal fixation conditions, and literature references are also indicated for each marker. ER81 has been described in monkey cortex (30, 31) and is presumably expressed in human layer V, although this has not been verified. migrate to deep/lower cortical layers and late-born neurons migrate to superficial/upper layers (61Y66).
Much evidence indicates that neuron identity, type, and laminar fate are specified during neurogenesis, before a new neuron begins migrating (Fig. 4B) (67, 68) . Neurogenesis and fate specification appear to be controlled by an intrinsic genetic program that can also be modulated by factors or interactions in the progenitor zone (69, 70) . Diversity of neuron types is achieved by the sequential production of different types of neurons from patterned progenitor compartments, according to well-defined temporal and spatial coordinates. Once specified, the neuron type identity and laminar fate are apparently impervious to change, even if cell migration is abnormal and the neuron migrates to an inappropriate location. The best example of this situation occurs in reeler mutant mice, in which deficiency of a secreted glycoprotein (reelin) causes abnormal cell migrations, leading to inversion of the laminar organization (Boutside-in[ cortex) (71) . Remarkably, the misplaced neurons in reeler express appropriate properties for the laminar fate they should occupy in normal cortex, despite the abnormal laminar organization. For example, subplate (layer VIb) neurons migrate to abnormally superficial positions in reeler cortex but still function to guide pioneer thalamocortical axons into the cortex, along abnormal subpial pathways (72) . Corticospinal axon connections and cortical barrels likewise develop in reeler despite the cortical disorganization (73) .
In addition to cell migration disorders, abnormal specification or differentiation of neuron type and laminar fate can also contribute to cortical disorganization and MCDs. In mice with targeted mutations of Fezl or Ctip2, the specification and differentiation of corticospinal neurons are defective (27, 74) . Similarly, Tbr1 inactivation perturbs the differentiation of early-born neuron types, leading to defects of layer-specific molecular expression, axon pathfinding, and cell migration (26) . In malformations involving defects of neuron type specification or differentiation, layerspecific markers can be particularly useful to demonstrate reduction or absence of certain neuron types, as well as altered laminar distribution.
Layer-Specific Markers in Cortical Malformations
Layer-specific markers have been used extensively in mice as probes for neuron types in cortical malformations as well as normal development. The reeler mutant cortex is particularly well studied as it has been the focus of intense research for many years. The overall inversion of the reeler neocortex was first demonstrated by cell birth-dating methods. Those early studies revealed that the reeler cortex developed by migration of early-born neurons to superficial positions and late-born neurons to deep positions, that is, opposite to the usual inside-out sequence (71) . More recent studies with numerous layer-specific markers have shown that patterns of molecular expression shift to abnormal laminar positions in reeler, as predicted from the overall cortical inversion (20, 22, 28) . Moreover, double labeling for cell birthday and molecular expression has verified that neurons in reeler express markers that would be appropriate for the same birthday in normal mice, despite their abnormal positions (20) . Thus, the correlations between cell birthday and neuron type are generally preserved, although some slight alterations in the neurogenesis of certain neuron types have been observed and attributed to effects of reelin deficiency on progenitor cells (73) . Finally, layer-specific markers have also revealed that neuron types do not simply conform to a strict inverted phenotype in reeler but also scatter more widely than normal across radial positions (20, 22, 28) .
Examples of layer-specific markers (Cux1 and Ctip2) in mutant mouse cortical malformations are shown in Figure 5 , along with corresponding cresyl violetYstained sections. Normally, transcription factors Cux1 and Ctip2 are expressed in upper and lower cortical layers of the neonatal mouse cortex, respectively (Fig. 5A, B) (27, 28, 74) . In the roughly inverted cortex of reeler, Cux1 + neurons shift to deep positions and Ctip2 + neurons to superficial positions, and laminar boundaries are blurred (Fig. 5C, D) . Tbr1 mutant cortex shows a strikingly different phenotype, with alternating patches of deep (Ctip2 + ) and superficial (Cux1 + ) type neurons, suggesting an abnormality of nonradial as well as radial cortical organization (Fig. 5E, F) (26) . These examples illustrate how molecular markers can reveal aspects of cortical organization that are not apparent with routine stains such as Nissl. The layer-specific markers act as molecular tags that not only identify individual cells but also precisely report the number and positions of different types of neurons. This type of analysis is now a mainstay of research on mouse cerebral cortex development but has only recently been introduced as an approach to studying human development and neuropathology. Very few studies have used layer-specific markers to analyze normal human cortex, MCDs, or epileptic foci (21, 39, 45Y56) . My laboratory has recently focused on transcription factor Tbr1, a specific marker for early-born neurons in mice (26) and normal humans (45) . In preliminary studies of a case of type II lissencephaly (WalkerWarburg syndrome), we found that the number of Tbr1 + neurons was overall reduced and that the remaining Tbr1 + neurons were widely scattered and did not form a distinct layer (Fig. 6) . Recently, Sheen et al (21) used Tbr1, as well as FoxP1 and other layer-specific markers, to study type I lissencephaly (Miller-Dieker syndrome). They found that the cortical organization was unexpectedly similar to normal cortex, despite the cortical thickening and laminar distortion due to impairment of cell migration. Their analysis contrasted sharply with conclusions reached by other groups using routine stains and neurofilament immunohistochemistry (18, 19) , and further studies will be necessary to resolve the discrepancies. These limited examples provide exciting glimpses of the tremendous potential of layer-specific markers to open new insights into the neuropathology of MCDs.
Present Challenges and Future Directions
Current trends suggest that layer-specific markers will be increasingly used to study all kinds of MCDs. It is hoped + neurons were reduced in number compared with normal, and were widely scattered in the disorganized cortex. Formalin-fixed, paraffin-embedded tissues with antigen retrieval. Scale bar = 500 Km. that such markers will reveal important details of cortical organization and neuronal composition that influence not only interpretations of pathogenesis but also diagnostic classification. Eventually, layer-specific markers may even become standard immunohistochemical probes in the neuropathologic diagnosis of MCDs. The biggest immediate barriers to wider use of layer-specific markers in human neuropathology are: 1) the paucity of layer-specific antibodies compatible with formaldehyde-fixed, paraffinembedded brain specimens and 2) the daunting task of documenting expression in normal human cortex at various developmental stages and in different cortical areas. Progress on the first problem will require the production of better antibodies and improvements to antigen retrieval in immunohistochemistry. Progress on the second problem will be driven by the need to compare MCDs with appropriate normal controls and by interest in basic mechanisms and principles of cerebral cortex development and organization in humans and nonhuman primates. More broadly, layer-specific markers represent an expanding universe of cell type-specific markers expressed in all areas of the CNS. Just as layer-specific markers will influence neuropathologic studies of MCDs, it is very likely that many other new markers will have a similar impact on studies of malformations in the spinal cord, hindbrain, cerebellum, midbrain, thalamus, and basal ganglia. As our knowledge of the genetic underpinnings of CNS malformations advances, molecular markers of neuron type will play an important role in establishing genotype-phenotype correlations and determining the range of phenotypic heterogeneity for particular mutations. Molecular markers of cell identity may also be valuable for identifying affected neuron types in neurodegeneration, hypoxiaYischemia, and other causes of neuron loss and for evaluating the efficacy of neural tissue regeneration using exogenous stem cells or endogenous progenitors (75) .
